Second-Generation Atroposelective Synthesis of KRAS G12C Covalent Inhibitor GDC-6036

A chromatography-free asymmetric synthesis of GDC-6036 (1) was achieved via a highly atroposelective Negishi coupling of aminopyridine 5 and quinazoline 6b catalyzed by 0.5 mol % [Pd(cin)Cl]₂ and 1 mol % (R,R)-Chiraphite to afford the key intermediate (R_a)-3. An alkoxylation of (R_a)-3 with (S)-N-methylprolinol (4) and a global deprotection generates the penultimate heterobiaryl intermediate 2. A controlled acrylamide installation by stepwise acylation/sulfone elimination and final adipate salt formation and crystallization delivered high-purity GDC-6036 (1).